On Tuesday, Precigen Inc (NASDAQ: PGEN) opened lower -6.04% from the last session, before settling in for the closing price of $1.82. Price fluctuations for PGEN have ranged from $0.65 to $2.17 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -19.53% over the past five years. Company’s average yearly earnings per share was noted 42.98% at the time writing. With a float of $162.39 million, this company’s outstanding shares have now reached $292.87 million.
Let’s look at the performance matrix of the company that is accounted for 143 employees. In terms of profitability, gross margin is -29.11%, operating margin of -3440.31%, and the pretax margin is -3261.86%.
Precigen Inc (PGEN) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Precigen Inc is 44.77%, while institutional ownership is 25.87%. The most recent insider transaction that took place on Aug 09 ’24, was worth 50,000. In this transaction SVP, IP Affairs of this company bought 58,823 shares at a rate of $0.85, taking the stock ownership to the 743,097 shares. Before that another transaction happened on Aug 09 ’24, when Company’s Director bought 23,529,411 for $0.85, making the entire transaction worth $19,999,999. This insider now owns 64,547,214 shares in total.
Precigen Inc (PGEN) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.08 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 42.98% per share during the next fiscal year.
Precigen Inc (NASDAQ: PGEN) Trading Performance Indicators
Check out the current performance indicators for Precigen Inc (PGEN). In the past quarter, the stock posted a quick ratio of 4.76. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 128.27.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.48, a number that is poised to hit -0.08 in the next quarter and is forecasted to reach 0.03 in one year’s time.
Technical Analysis of Precigen Inc (PGEN)
Precigen Inc (NASDAQ: PGEN) saw its 5-day average volume 1.56 million, a negative change from its year-to-date volume of 1.97 million. As of the previous 9 days, the stock’s Stochastic %D was 45.45%. Additionally, its Average True Range was 0.15.
During the past 100 days, Precigen Inc’s (PGEN) raw stochastic average was set at 69.71%, which indicates a significant increase from 24.24% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 56.50% in the past 14 days, which was lower than the 92.60% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.6179, while its 200-day Moving Average is $1.2464. Nevertheless, the first resistance level for the watch stands at $1.8033 in the near term. At $1.8967, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.9633. If the price goes on to break the first support level at $1.6433, it is likely to go to the next support level at $1.5767. The third support level lies at $1.4833 if the price breaches the second support level.
Precigen Inc (NASDAQ: PGEN) Key Stats
There are currently 294,043K shares outstanding in the company with a market cap of 502.81 million. Presently, the company’s annual sales total 3,930 K according to its annual income of -126,240 K. Last quarter, the company’s sales amounted to 1,190 K and its income totaled -19,730 K.
